After the National Institutes of Health (NIH) announced late Friday that it would be following a Trump administration directive to cut the cost of medical research grants, major makers of DNA ...

Illumina shares surge 98.7% in a year as NovaSeq X adoption accelerates, clinical sequencing demand grows, and the company tops Q1 2026 guidance.

Illumina stock slid on Tuesday after China banned imports of the biotech’s gene sequencing machines as part of a broader retaliatory response to U.S. tariffs.

Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, recently announced that its HiFi whole-genome sequencing technology has been adopted as a first-line approach in a major ...